International Journal of Breast Cancer · Published 2025-01-01 · DOI 10.1155/ijbc/8856457
Conclusion: CCL18 shows strong prognostic and immunological relevance in BRCA, while EGF appears to play a broader oncogenic role. Hypomethylation of both genes may drive their aberrant expression and involvement in tumor progression.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →